Cannabis and work
With the legalization of recreational marijuana in Canada, workplaces are concerned about its implications for workplace health, safety and productivity. IWH researchers are watching the research literature and conducting their own studies in order to help answer questions about marijuana use at work: its scope, its effects, and its relationship to work-related injuries and deaths.
Featured
Research Highlights
Workers are using cannabis to treat work-related conditions, mostly without medical guidance
While cannabis is often used recreationally, there is growing interest in its use for therapeutic purposes, such as for pain, anxiety, depression and sleep problems. Some workers are using cannabis many months following the onset of a work-related condition, mostly without medical guidance.
Published: October 5, 2023
IWH Speaker Series
Cannabis use and the risk of workplace injury: Findings from a longitudinal study of Canadian workers
In this presentation, Dr. Nancy Carnide shares new findings from a longitudinal study of Canadian workers looking at the relationship between cannabis use and workplace injury—including workplace use.
Published: March 8, 2022
IWH in the media
Marijuana in the workplace: What is unsafe?
The federal government’s commitment to legalize recreational marijuana by July 1, 2018 raises occupational health and safety concerns for many employers. At the Institute for Work & Health (IWH), we have been reviewing the effects of various drugs that act on the central nervous system — including marijuana — on workplace injuries, deaths and near-misses, write IWH's Dr. Andrea Furlan and Dr. Nancy Carnide. What is striking is how little high-quality evidence there is on the impacts of marijuana in the workplace and how inconsistent the existing data is.
Published: The Conversation, January 2018
IWH in the media
Companies fret about hazy rules around pot use
Once recreational cannabis use becomes legal, taking a “smoke break” at work could suddenly become much more complicated, writes Cassandra Szklarski of the Canadian Press. The Institute for Work & Health's Dr. Andrea Furlan and Dr. Nancy Carnide are among those interviewed.
Published: National Post, December 2017
IWH in the media
Weed at work
The legalization of recreational marijuana in Canada came closer to reality on April 13, when the Justin Trudeau government introduced the Cannabis Act, or Bill C-45. While pot users across the country applaud the move, others have raised concerns about the effect that the proposed legislation would have on workplace safety, writes Jeff Cottrill in an article that quotes the Institute for Work & Health's Dr. Andrea Furlan.
Published: OHS Canada, August 2017
Project
Project
Central nervous system agents and the risk of workplace injury and death: a systematic review
IWH is leading a systematic review to determine the level and quality of research evidence on the association between workers’ use of agents that act on the central nervous system (e.g. opioids, cannabis) and the risk of workplace injury, reinjury, near misses and death, including outcomes affecting co-workers and others in the immediate workplace.
Status: Completed 2019